“Successful Benralizumab Therapy for Severe Asthma Secondary to EGPA Refractory to Mepolizumab”. Revista Alergia México, vol. 72, no. 3, Sept. 2025, p. 216, https://doi.org/10.29262/ram.v72i3.1490.